Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Journal article, 2008
It is of great significance to find better markers to correctly distinguish between high-risk and low-risk breast cancer patients since the majority of breast cancer cases are at present being overtreated.
Follow-Up Studies
Kaplan-Meier Estimate
genetics
mortality
Biological
Female
Tumor Markers
genetics
Ductal
pathology
Humans
diagnosis
Breast
Gene Expression Profiling
Cluster Analysis
genetics
Predictive Value of Tests
Breast Neoplasms
Oligonucleotide Array Sequence Analysis
pathology
mortality
Lymphatic Metastasis
Carcinoma
diagnosis
Prognosis
Middle Aged
Author
Elin Karlsson
University of Gothenburg
Ulla Delle
University of Gothenburg
Anna Danielsson
University of Gothenburg
Björn Olsson
Frida Abel
University of Gothenburg
Per Karlsson
University of Gothenburg
Khalil Helou
University of Gothenburg
BMC Cancer
14712407 (eISSN)
Vol. 8 254-Subject Categories
Basic Medicine
Clinical Medicine
DOI
10.1186/1471-2407-8-254
PubMed
18778486